Greater access to life-changing medicine for Australians with ADHD

Australian adults living with Attention Deficit Hyperactivity Disorder (ADHD) will soon have more affordable access to a life-changing treatment option, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS).   On 1 February, the Government is expanding the listing of Vyvanse® (lisdexamfetamine) to include patients who are diagnosed with ADHD after they turn…

Transcript – Doorstop – Somerville

E&OE…                       Topics: COVID-19 update, Travel arrangements with New Zealand, Vaccine rollout; CSL production of AstraZeneca; EU delays; Germany’s claims on AstraZeneca; Novavax; Britain/UAE border closure; South African variant of the virus; National booking system   GREG HUNT: I’m pleased to be able to provide an update both in terms of COVID-19 and cases in…

Transcript – Press Conference – Canberra

E&OE…                       Topics: suspension of travel arrangements with NZ     GREG HUNT: I’m joined by Professor Michael Kidd, the Acting Chief Medical Officer, and we’re here to report on advice from the medical expert panel, or AHPPC, received during the course of the afternoon to the Government and upon which the Government has acted.…

Pfizer vaccine approved

The Therapeutic Goods Administration (TGA) has today provisionally approved the Pfizer/BioNTech COVID-19 vaccine for use in Australia. The Pfizer vaccine has met strict standards for safety, quality and efficacy. The TGA provisional approval is for individuals 16 years of age and older. Two doses will be required – at least 21 days apart. A priority…